or
forgot password

    • cancer clinical trials in bozeman, MT

    • Methylphenidate in Treating Patients With Fatigue Caused by Cancer
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Melanoma (Skin)
    Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Breast Cancer
    Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Breast Cancer, Dermatologic Complications, Radiation Toxicity, Skin Reactions Secondary to Radiation Therapy
    Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Melanoma (Skin)
    Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Pancreatic Cancer
    Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Brain and Central Nervous System Tumors
    Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Breast Cancer
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    S0309, Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma, Waldenstrom's Macroglobulinemia, Amyloidosis, or Monoclonal Gammopathy of Undetermined Significance
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition
    S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Light Chain Deposition Disease, Primary Systemic Amyloidosis